Carcinoid Tumors
March 2019 Issue

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Carcinoid Tumors abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Carcinoid Tumors. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Carcinoid Tumors. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Carcinoid Tumors every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content, Inc.

1:Sclerosing pneumocytoma mixed with a typical carcinoid tumor: A case report and review of literature.
Authors:Wang Z, Yang MQ, Huang WJ, Zhang D, Xu HT
Institution:Department of Pathology, the First Hospital and College of Basic Medical Sciences of China Medical University, Shenyang.; Department of Pathology, General Hospital of Heilongjiang Land Reclamation Bureau, Harbin.; Department of Pathology, Changyi People's Hospital, Changyi, China.
Journal:Medicine (Baltimore). 2019 Feb;98(5):e14315. doi: 10.1097/MD.0000000000014315.

2:Case of Solitary Peritoneal Metastasis From Atypical Bronchopulmonary Carcinoid on 18F-FDG PET/CT.
Authors:Gawde S, Singhal A, Kasat A, Parekh S, Ramaswamy V
Institution:From the Departments of Nuclear Medicine and PET/CT, and.
Journal:Clin Nucl Med. 2019 Mar;44(3):e154-e157. doi: 10.1097/RLU.0000000000002441.

3:Hemolytic Anemia and Gastric Carcinoid in a Russian Seafarer: Highlighting the Role of Diagnostic Technologies in Modern Clinical Practice.
Authors:Chaunzwa TL, O'Shea J, Boggs NA, Schwartz JI, Gibson J, Gielissen KA
Institution:Yale School of Medicine, New Haven, CT.
Journal:Yale J Biol Med. 2018 Sep 21;91(3):243-246. eCollection 2018 Sep.

4:CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report.
Authors:Del Gobbo A, Fusco N, Barella M, Ercoli G, Sciarra A, Palleschi A, Pagni F, Marchio C, Papotti M, Ferrero S
Institution:Division of Pathology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, University of Milan, Via Francesco Sforza 35, 20122, Milan, Italy.; Department of Biomedical, Surgical, and Dental Sciences, University of Milan, Milan, Italy.; School of Medicine, University of Milan, Milan, Italy.; Department of Thoracic Surgery, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.; Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
Journal:Cell Oncol (Dordr). 2018 Dec;41(6):687-691. doi: 10.1007/s13402-018-0401-9. Epub 2018 Sep 4.

5:Atypical carcinoid of the uterine cervix accompanying adenocarcinoma in situ.
Authors:Ling C, Shen Y
Institution:Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu, People's Republic of China. China. (Sichuan University), Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, People's Republic of China.
Journal:J Clin Pathol. 2018 Nov;71(11):1030. doi: 10.1136/jclinpath-2018-205081. Epub 2018 Aug 28.

6:Economic analysis of inadequate symptom control in carcinoid syndrome in the United States.
Authors:Burton T, Lapuerta P
Institution:Optum Life Sciences, Health Economics and Outcomes Research, Boston, MA 02215, USA.
Journal:Future Oncol. 2018 Oct;14(23):2361-2370. doi: 10.2217/fon-2018-0129. Epub 2018 Aug 10.

7:Exercise cardiac magnetic resonance imaging with pulmonary artery catheter monitoring in carcinoid heart disease: a shift towards early intervention?
Authors:Timmermans P Jr, Rega F, Bogaert J, Herregods MC
Institution:Division of Cardiology, University Hospital Leuven, Herestraat 49, 3000, Leuven, Belgium. Belgium.
Journal:ESC Heart Fail. 2018 Oct;5(5):953-955. doi: 10.1002/ehf2.12328. Epub 2018 Aug 6.

8:A Rare Case of Ampullary Goblet Cell Carcinoid.
Authors:Shibuya H, Hijioka S, Mizuno N, Kuwahara T, Okuno N, Tanaka T, Ishihara M, Hirayama Y, Oonishi S, Murakami Y, Yatabe Y, Tajika M, Niwa Y, Hara K
Institution:Departments of Gastroenterology, Aichi Cancer Center Hospital, Japan. University School of Medicine, Japan. Hospital, Japan. Japan. Japan.
Journal:Intern Med. 2018 Sep 1;57(17):2489-2496. doi: 10.2169/internalmedicine.0516-17. Epub 2018 Mar 30.

For a FREE PREVIEW of the Medifocus Guidebook on Carcinoid Tumors click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Carcinoid Tumors click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

Get the Medifocus Guidebook on Carcinoid Tumors...
at a Special 20% Discount

Medifocus Guidebook on Carcinoid Tumors

Updated: January 2, 2019
166 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
  • Timely, up to date content with free guidebook updates for 1 year.
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
  • Over 130,000 Guidebooks Sold
  • 100% Risk Free Money Back Guarantee


The Medifocus Guidebook on Carcinoid Tumors is available in the following two convenient formats:


Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook


Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook

Order by Phone

Call Toll Free in the U.S.

From Outside the U.S.

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders


Coupon Expires: July 18, 2019

What Our Customers Are Saying...

"The MediFocus Guidebook on Carcinoid Tumors helped me prepare for my operation. It was reassuring to be able to communicate with my surgeon and the consulting doctors having knowledge about my condition."
Newcastle, England

"The Guide is detailed and written in a way that the layman can readily understand. My wife, who has just had a Carcinoid Tumor removed, is reading it as I write this. It will be helpful in her recovery and ongoing therapy."
Nanaimo, British Columbia

"The MediFocus Guidebook on Carcinoid Tumors was extremely informative and easy to understand. Now I'm able to discuss my condition with my doctor in an informed manner and make better decisions regarding my treatment."
Agoura Hills, California

Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2019 Medifocus, Inc. All rights reserved.